These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38739313)

  • 21. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma].
    Onisk Z; Tchórzewski H
    Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostaglandin E1 in systemic sclerosis.
    Biltz H; Küster W; Lüders G; Wehrmann W; Ammari B; Kreysel HW
    Prog Clin Biol Res; 1989; 301():469-73. PubMed ID: 2571994
    [No Abstract]   [Full Text] [Related]  

  • 23. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
    Czirják L; Surányi P; Dankó K; Szegedi G
    Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T cells in systemic sclerosis.
    Fuschiotti P
    Immunol Res; 2011 Aug; 50(2-3):188-94. PubMed ID: 21717073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?
    De Palma R; D'Aiuto E; Vettori S; Cuoppolo P; Abbate G; Valentini G
    Rheumatology (Oxford); 2010 Jul; 49(7):1257-66. PubMed ID: 20418226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disorders of cellular immunity in systemic scleroderma].
    Sierakowski SJ; Kucharz EJ
    Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641
    [No Abstract]   [Full Text] [Related]  

  • 28. T-cell receptors in scleroderma skin. The effect of photopheresis.
    Williams WV; Rook AH; Freundlich BF; Fang Q; Shaw E; Lessin S; Weiner DB
    Ann N Y Acad Sci; 1995 Jul; 756():424-7. PubMed ID: 7645864
    [No Abstract]   [Full Text] [Related]  

  • 29. Beneficial effects of antithymocyte globulin in severe cases of progressive systemic sclerosis.
    Tarkowski A; Lindgren I
    Transplant Proc; 1994 Dec; 26(6):3197-9. PubMed ID: 7998113
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic factors and systemic sclerosis.
    Murdaca G; Contatore M; Gulli R; Mandich P; Puppo F
    Autoimmun Rev; 2016 May; 15(5):427-32. PubMed ID: 26826434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current findings in progressive systemic sclerosis].
    Zanussi C; Ortolani C; Pastorello E; Riboldi PS; Sabbadini MG
    Minerva Med; 1982 Apr; 73(18):1189-200. PubMed ID: 7043320
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral blood lymphocyte distribution in scleroderma.
    Carapeto FJ; Winkelmann RK
    Dermatologica; 1975; 151(4):228-35. PubMed ID: 773715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis.
    Urano J; Kohno H; Watanabe T
    Eur J Pediatr; 1981 Jul; 136(3):285-9. PubMed ID: 6973466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immune dysfunction and the pathogenesis of scleroderma.
    Jiménez SA
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):104-13. PubMed ID: 6353581
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of T cells and cytokines in effecting fibrosis.
    Postlethwaite AE
    Int Rev Immunol; 1995; 12(2-4):247-58. PubMed ID: 7650423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
    Sakkas LI; Chikanza IC; Platsoucas CD
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelial tissue factor induction by T lymphocytes in systemic sclerosis.
    Della Bella S; Mussoni L; Molteni M; Colli S; Zulian C; Camera M; Tremoli E; Scorza R
    Clin Rheumatol; 1999; 18(1):38-41. PubMed ID: 10088947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.